Member Info for oilmanmike

Just forgot to add that when Pharma realises a vaccine is futile they will
be fighting over control of SNG IP. Ie patent for the drug and the delivery system.
Simple Fact IMO

Manifesto
Have you watched the Rockefella Lecture yet!?
say it all IMO
100% in agreement with Holgate's findings.
This should be a lot lot higher that it is for
what we now know.
P3 FDA is a formality.
There is a big market for SNG0001 in the making
as it now transpires vaccines may not work in
many cases which may be caused by an auto immunity
deficiency. i.e the body fails to recognise the virus initially
leading to life threatening COVID phenomena . In these cases
it seems that a vaccine would not be effective and for those
with a strong system a vaccine is not needed because they
have no problem shaking off the virus.
Big Pharma will not be pleased with these findings out of
Rockefella but if correct they mean a vaccine is a waste
of time and money.
Far better to introduce SNG0001 early to help those with
genetically low levels of interferons or auto immunity which
is why Holgate is so excited about the home trials
People have missed this very important development out
of the US last night. Question is whether the Yanks have also
missed it.

The lecture supports 100% what Prof Sir Stephen Holgate is saying.
SNG have the global patent for inhaled INT 1 Beta 1a which is SNG0001.
It seems to me that the FDA phase trials are a formality given the findings
of this NEW research. This is effectively a Peer study in agreement with
the 'mechanics' for what SNG have discovered.
It all adds up to the price being a lot lower than it should be given where
we are and what we now know...............Venrock knows where this is heading.

Dacorum you are significantly behind on the curve here.
Bargin at 180p
it may never get to 175p as the advantage of only five pence
would outweigh dealing costs on the smaller amounts most
PI'S HOLD.

There is a senior BBC Covid journalist chairing a on line Covid forum at Southampton this evening.

at 186p IMHO.
when any loose stocks cleared this will move up nicely.
Meantime we await peer review, home trials and more
detail on the FDA phase3 trials

with the new shares available today if MM do not see the selling the drop in price anticipated then they will have to walk it back up. Therefor we may not see 175p, furthermore if it starts to climb from here then all those who sold or are waiting will have to make a move!! Just my humble opinion.

I would have expected existing II's to have taken some in the 1st round of the placing.
eg Venrock who I believe hold around 5.5%. Unless they were happy to subscribe for
what they needed to stay at the same % which would be c 2.5m shares.
I do not see them selling any time soon.

they have lent out some stock
So shorter still active imo

it's regular staff
not directors.
That was their bonus

I was working on £500 profit per unit.
Total 100,000 x 500 x 12 = 600m per year
on a multiple of 10 X
gives sp of £30

Hence Numis £9 to £50 target price

I would imagine that over the last couple of weeks they have had a lot more cases and so finding suitable participants has been
easier than over the summer after the initial first wave. The real point is that once somebody enters hospital needing assistance the result for that particular patient is known within a couple of weeks. Ie did it work or not.
I believe the trial is taking place in 20 countries to speed up the availability of the data. I see this as a big big positive here.

The other big positive is the presence of Venrock on the shareholder register, but that is a different matter.

PJ when will we find out what happened at the meeting?
And how
TIA

register in the next 6 mins if you want to watch.!!

Robert have you a link to tonights lecture?
TIA

they will be though

PJ can you confirm that the date of the second was before RM made the comment.
TIA

fair enough, but I have seen plenty of stocks break the mould.
It all depends on supply demand.
Any significant SNG0001 news and this will move much higher
to a level that mitigates the risk of sticking with it compared
to selling and buying back 12% lower.
It may be a long wait for you or you may never see 175p to buy
meantime this could start it's next leg any time.

twunt

that's some big hope since they still have 148m shares to sell!